Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer(FLEX)

This study is ongoing, but not recruiting participants.

Study NCT00148798 Information provided by Merck KGaA

First Received: September 7, 2005 Last Updated: September 2, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	May 2007
Estimated Primary Completion Date:	June 2010 (Final data collection date for primary outcome measure)